XORTX Therapeutics Inc. (XRTX) Stock
XRTX Key Statistics
About XORTX Therapeutics Inc.
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is based in Vancouver, Canada.
CEO: Allen Warren Davidoff. Company website
XRTX — Frequently Asked Questions
What is the XRTX stock price today?
XORTX Therapeutics Inc. (XRTX) trades at $1.90, up 34.61% on the day, as of Nov 12, 2026 10:46 UTC.
What is XORTX Therapeutics Inc.'s market cap?
XORTX Therapeutics Inc. has a market capitalisation of $528,572.12, calculated from the live XRTX share price and shares outstanding.
What is the P/E ratio of XRTX?
XRTX has no meaningful price-to-earnings ratio: XORTX Therapeutics Inc. lost $16.00 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does XORTX Therapeutics Inc. make?
XORTX Therapeutics Inc. generated revenue of $0.00 over the trailing twelve months.
What is the 52-week range for XRTX?
XRTX has traded between $1.36 and $3.60 over the past 52 weeks, and the last price is 47.3% below that high.
Is XORTX Therapeutics Inc. profitable?
Yes. XORTX Therapeutics Inc. keeps 0.00% of revenue as net income over the trailing twelve months.
What sector is XORTX Therapeutics Inc. in?
XORTX Therapeutics Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in CA .
Who is the CEO of XORTX Therapeutics Inc.?
Allen Warren Davidoff is the chief executive of XORTX Therapeutics Inc., which employs 2 people.
Where can I track XRTX in real time?
QFI Terminal shows XRTX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See XRTX live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open XRTX in Terminal See plans